PEStore

Buyout PE

Impilo

Impilo acquires controlling stakes in established, profitable businesses, from Stockholm, Sweden. It states a focus on healthcare & life sciences.

Disclosed holdings12
Earliest stated investment
HeadquartersStockholm, Sweden
Largest single fundNot stated

Portfolio

Disclosed holdings

Companies Impilo lists on its own website. No investment years are published.

CompanyInvestedYears heldRecorded transaction
Avia Pharma
Decon
Euro Accident
Humana
Immedica
Lowenco
Pelago Bioscience
Qufora
Scantox
Stille
VaccinDirekt
tandlægen.dk

Compiled from Impilo’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Impilo?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other buyout pe investors active in healthcare & life sciences.